Simmons First Trust’s Bristol-Myers Squibb BMY Stock Holding History

Simmons First Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.58M	Buy	+22,923	New	+$1.51M	0.18%	114

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Simmons First Trust's BMY Position: Q4 2015 in Review

Simmons First Trust opened a new position in Bristol-Myers Squibb (BMY) in Q4 2015: 22,923 shares worth $1.58M. The stake represents 0.18% of the portfolio and ranks #114 among its holdings.

1,534 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

Simmons First Trust held 22,923 shares of Bristol-Myers Squibb worth $1.58M as of Q4 2015.
Bristol-Myers Squibb was a new Simmons First Trust position in Q4 2015.
Bristol-Myers Squibb made up 0.18% of Simmons First Trust's portfolio in Q4 2015, its #114 holding.
1,534 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Simmons First Trust's 13F filing for Q4 2015, filed 1 Feb 2016.